Navigation Links
Towards an efficient, effective and equitable REDD+
Date:12/7/2010

ergovernmental Panel on Climate Change (IPCC) accounting rules for Agriculture, Forestry and Other Land Use (AFOLU) provides a simple alternative: include all land use proportionate to actual emissions and emission potential. A whole-landscape approach can help address the drivers of deforestation, reduce problems like leakage, and eliminate the need for precise forest definitions.

According to Dr. Peter Minang, The Global Coordinator of the ASB Partnership for Tropical Forest Margins, there are strategies that can be adopted by developing countries.

"We are compiling evidence that shows how developing countries can adopt strategies for these high-carbon storing land-uses to reduce global emissions and benefit local people," says Dr. Minang.

According to Dr. van Noordwijk:"Four 'pillars' that support a whole landscape agenda must be considered." He lists the four pillars as "Reducing forest-based emissions, Reducing emissions from peat, Restocking land through trees and soil carbon, and Reducing emissions from agricultural greenhouse gases."

"What is needed now is a global commitment to move forward, comprehensively, to reduce emissions from all land uses," adds Dr. Neufeldt.

Emissions embodied in trade may well be the hottest issues in trying to reduce emissions from land use: much of the emissions due to change in forest is linked to export and the responsibility for these emissions will have to be shared by the importing as well as exporting countries, for a fair and efficient accounting system.

Before REDD projects are able to cut carbon emissions and benefit livelihoods, many developing countries will require substantial investments in capacity building, science and institutions. For example, countries will need technical support to develop carbon inventory systems and their remote sensing capacity. In addition, they will need support to set up the institutional infrastructure required to distribute REDD
'/>"/>

Contact: Paul Stapleton
p.stapleton@cgiar.org
254-717-718-387
World Agroforestry Centre
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Scientists announce major progress towards historic Census of Marine Life in 2010
2. Attitudes towards assisted reproduction and preimplantation genetic diagnosis
3. Oceans journey towards the center of the Earth
4. Cancer: Another step towards medication
5. Towards a natural pacemaker
6. Discovery of a new molecular mechanism that guides visual nerves towards the brain
7. Striding towards a new dawn for electronics
8. Scientist IDs genes that promise to make biofuel production more efficient, economical
9. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
10. Commercial aquatic plants offer cost-effective method for treating wastewater
11. RNA molecules, delivery system improve vaccine responses, effectiveness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... new twist on the slogan “milk does a body ... a contrast agent in gastrointestinal imaging exams—with excellent results. ... meeting of the Radiological Society of North America (RSNA). ... and enhancement as we see with the commonly used ...
... Scientists at the University of California, San Diego and ... by Bacillus thuringiensis, a bacterium sprayed on crops by ... at treating hookworm infections in laboratory animals. , ... of the Proceedings of the National Academy of Sciences, ...
... to higher global temperatures may be somewhat overstated as ... adjust to changing conditions, according to researchers from Oak ... April 28 by Science, a team led by Tony ... more carbon will be stored in plants and soil ...
Cached Biology News:Got inexpensive contrast agent? Milk plays new role in imaging 2Bacterial protein shows promise in treating intestinal parasites 2Bacterial protein shows promise in treating intestinal parasites 3Plants' role in global warming re-examined 2
(Date:7/30/2015)... KANSAS CITY, Kan. , July 30, 2015 ... PETX ), a pet therapeutics company focused on ... products for companion animals, today announced that its ... results from a dose confirmation study of AT-016, ... to Aratana for the treatment of osteoarthritis pain ...
(Date:7/30/2015)... July 30, 2015 HIGHLIGHTS:Q2 2015 ... 2014) , Reported sales were $697 million compared ... Sales grew organically by 8%, and changes in foreign ... increased sales by 1%. , By business unit, ... Applied and 11% in SAFC Commercial. , Reported ...
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... Japan (Q2 2015: +14% CER / 20% of sales) led the ... China , as well as solid contributions from Korea, ... / Middle East / Africa ... Germany , Turkey and the ... sales) grew 11%, excluding U.S. HPV sales, on demand across all customer classes. ...
Breaking Biology Technology:Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
... Millennium,Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) ... elected President and Chief Operating Officer of,Millennium ... Mirken,brings more that 18 years of combined ... to Millennium. Mr. Mirken was President,and Chief ...
... HOST CONFERENCE CALL AT 10:00AM EDT, EDMONTON, ... BIOM ) (TSX: BRA) (the "Company") today ... a proposal to change its,jurisdiction of incorporation from ... Delaware in the United States of America through ...
... System Facilitates Minimally Invasive and Robotic-Assisted Coronary ... Artery Bypass ... CRDC ) today announced that it has received European CE Mark,(Conformite ... A system is a variation of Cardica,s C-Port(R) xA,Distal Anastomosis System ...
Cached Biology Technology:Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer 2Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery 2Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery 3
...
... Set from different Cynomolgus monkey normal ... maybe available upon request. Customers ... the whole set, and pay 70% ... All Dr. P Set products are ...
... system consists of AmnioMAX-C100 ... 17001-082) and AmnioMAX-C100 Supplement ... is complete with antibiotics ... and requires no further ...
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C...
Biology Products: